Randomized Controlled Trial: Dupilumab in Glucocorticoid-Dependent Severe Asthma
23 May, 2018 | 12:39h | UTCRelated Article: Dupilumab Efficacy and Safety in Moderate-to-Severe Uncontrolled Asthma – New England Journal of Medicine (free)
Editorial: New Biologics for Asthma (free)
Commentary: Dupilumab Improves Severe Asthma – NEJM Physician’s First Watch (free)